This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Technion Research & Development Foundation Ltd, University of Utah Research Foundation. Active years: 2020-2023.
Company Filing History:
2 out of 999 
2 out of 1,684 
Years Active: 2020-2023
Title: Lisa Abegglen: Innovator in Cancer Research
Introduction
Lisa Abegglen is a prominent inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of cancer research, focusing on innovative methods and compositions for cancer treatment. With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Abegglen's latest patents include groundbreaking methods and compositions for preventing or treating cancer. The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences. This innovative approach highlights her commitment to advancing cancer treatment.
Career Highlights
Throughout her career, Lisa has worked with esteemed organizations such as the University of Utah Research Foundation and Technion Research & Development Foundation Ltd. Her experience in these institutions has allowed her to collaborate with leading experts in the field.
Collaborations
Some of her notable coworkers include Joshua Schiffman and Avi Schroeder. Their collaborative efforts have contributed to the advancement of cancer research and the development of new treatment methodologies.
Conclusion
Lisa Abegglen's innovative work in cancer research exemplifies her dedication to improving treatment options for patients. Her patents and collaborations reflect her significant impact on the scientific community.